Tag: Cancer: Prostate
Radiation Tx Impact Varies With Comorbidity in Prostate Cancer
Reduction in overall, cardiac mortality for RT alone in men with severe or moderate comorbidity
EHR Triggers Cut Time to Diagnostic Cancer Evaluation
Findings among veterans flagged for delayed diagnosis of prostate, colorectal cancer
Mushroom Powder Shows Potential in Prostate Cancer
Reduction in prostate-specific antigen level in some patients with biochemical recurrence
New Rx Strategy May Up Survival in Advanced Prostate Cancer
Adding chemotherapy to hormone therapy added 14 months to patients' lives in study
Targeted Prophylaxis Effective in Post-Prostate Biopsy Sepsis
Targeted prophylaxis similarly effective to empirical prophylaxis after transrectal prostate biopsy
Prostate Cancer Interacts With Comorbidity to Increase VTE Rate
Increased VTE risk among older patients, those with metastases, those who underwent surgery
Many Low-Risk Prostate Cancer Cases Upgraded at Prostatectomy
Upgrading, up staging linked to age >60, PSA >5.0 ng/ml, and >25 percent positive cores
More Radiation Doesn’t Up Survival in Low-Risk Prostate CA
But higher doses may improve survival in men with intermediate- and high-risk prostate cancers
Surveillance Becoming More Common for Prostate Cancer
Many men with low-risk disease being spared prostatectomy, radiation, androgen deprivation tx
Too Few Prostate Cancer Patients Receiving Active Surveillance
Researchers find 12 percent or fewer U.S. men with low-risk prostate cancer getting active surveillance
